AACR logo

Most cited article(s)

Anti-CTLA-4 Antibodies of IgG2a Isotype Enhance Antitumor Activity through Reduction of Intratumoral Regulatory T Cells
Mark J. Selby, John J. Engelhardt, Michael Quigley, Karla A. Henning, Timothy Chen, Mohan Srinivasan, Alan J. Korman

Cancer Immunology Research Jul 2013, 1 (1) 32-42; DOI: 10.1158/2326-6066.CIR-13-0013
Induction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic Carcinoma
Rafael Winograd, Katelyn T. Byrne, Rebecca A. Evans, Pamela M. Odorizzi, Anders R.L. Meyer, David L. Bajor, Cynthia Clendenin, Ben Z. Stanger, Emma E. Furth, E. John Wherry, Robert H. Vonderheide

Cancer Immunology Research Apr 2015, 3 (4) 399-411; DOI: 10.1158/2326-6066.CIR-14-0215
Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignancies
Gregory L. Beatty, Andrew R. Haas, Marcela V. Maus, Drew A. Torigian, Michael C. Soulen, Gabriela Plesa, Anne Chew, Yangbing Zhao, Bruce L. Levine, Steven M. Albelda, Michael Kalos, Carl H. June

Cancer Immunology Research Feb 2014, 2 (2) 112-120; DOI: 10.1158/2326-6066.CIR-13-0170
PD-L1 Expression in Triple-Negative Breast Cancer
Elizabeth A. Mittendorf, Anne V. Philips, Funda Meric-Bernstam, Na Qiao, Yun Wu, Susan Harrington, Xiaoping Su, Ying Wang, Ana M. Gonzalez-Angulo, Argun Akcakanat, Akhil Chawla, Michael Curran, Patrick Hwu, Padmanee Sharma, Jennifer K. Litton, Jeffrey J. Molldrem, Gheath Alatrash

Cancer Immunology Research Apr 2014, 2 (4) 361-370; DOI: 10.1158/2326-6066.CIR-13-0127
Immunotherapy Converts Nonimmunogenic Pancreatic Tumors into Immunogenic Foci of Immune Regulation
Eric R. Lutz, Annie A. Wu, Elaine Bigelow, Rajni Sharma, Guanglan Mo, Kevin Soares, Sara Solt, Alvin Dorman, Anthony Wamwea, Allison Yager, Daniel Laheru, Christopher L. Wolfgang, Jiang Wang, Ralph H. Hruban, Robert A. Anders, Elizabeth M. Jaffee, Lei Zheng

Cancer Immunology Research Jul 2014, 2 (7) 616-631; DOI: 10.1158/2326-6066.CIR-14-0027
Myeloid-Derived Suppressor Cells
Dmitry I. Gabrilovich

Cancer Immunology Research Jan 2017, 5 (1) 3-8; DOI: 10.1158/2326-6066.CIR-16-0297
An Abscopal Response to Radiation and Ipilimumab in a Patient with Metastatic Non–Small Cell Lung Cancer
Encouse B. Golden, Sandra Demaria, Peter B. Schiff, Abraham Chachoua, Silvia C. Formenti

Cancer Immunology Research Dec 2013, 1 (6) 365-372; DOI: 10.1158/2326-6066.CIR-13-0115
Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi, Donald Lawrence, Cecilia Lezcano, Xinqi Wu, Jun Zhou, Tetsuro Sasada, Wanyong Zeng, Anita Giobbie-Hurder, Michael B. Atkins, Nageatte Ibrahim, Philip Friedlander, Keith T. Flaherty, George F. Murphy, Scott Rodig, Elsa F. Velazquez, Martin C. Mihm, Sara Russell, Pamela J. DiPiro, Jeffrey T. Yap, Nikhil Ramaiya, Annick D. Van den Abbeele, Maria Gargano, David McDermott

Cancer Immunology Research Jul 2014, 2 (7) 632-642; DOI: 10.1158/2326-6066.CIR-14-0053
Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery
Suzanne I.S. Mosely, John E. Prime, Richard C.A. Sainson, Jens-Oliver Koopmann, Dennis Y.Q. Wang, Danielle M. Greenawalt, Miika J. Ahdesmaki, Rebecca Leyland, Stefanie Mullins, Luciano Pacelli, Danielle Marcus, Judith Anderton, Amanda Watkins, Jane Coates Ulrichsen, Philip Brohawn, Brandon W. Higgs, Matthew McCourt, Hazel Jones, James A. Harper, Michelle Morrow, Viia Valge-Archer, Ross Stewart, Simon J. Dovedi, Robert W. Wilkinson

Cancer Immunology Research Jan 2017, 5 (1) 29-41; DOI: 10.1158/2326-6066.CIR-16-0114
The Nonsignaling Extracellular Spacer Domain of Chimeric Antigen Receptors Is Decisive for In Vivo Antitumor Activity
Michael Hudecek, Daniel Sommermeyer, Paula L. Kosasih, Anne Silva-Benedict, Lingfeng Liu, Christoph Rader, Michael C. Jensen, Stanley R. Riddell

Cancer Immunology Research Feb 2015, 3 (2) 125-135; DOI: 10.1158/2326-6066.CIR-14-0127

Main menu

User menu

Search

Most cited article(s)

Pages

Articles

Info for

About Cancer Immunology Research